Patrick Michael Jedlowski (Patrick M Jedlowski)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Emergency Department

Coronavirus Disease

Squamous Cell Carcinoma

Top Venues

Journal of cutaneous medicine and surgery

American journal of clinical dermatology

Lasers in medical science

Proceedings (Baylor University. Medical Center)

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick Michael Jedlowski, Tracy L Davis, Sierra C Wolter
Annular plaques and nodules at vaccination sites in an infant. Pediatric dermatology 40 (6) (2023)
Patrick Michael Jedlowski, Michelle Anthony
Use of fractionated laser therapy for the treatment of androgenetic alopecia: a systematic review and meta-analysis. Lasers in medical science 39 (1) (2023)
Patrick Michael Jedlowski, Jason P DuPont
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event reporting system. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Patrick Michael Jedlowski
Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS). Journal of cutaneous medicine and surgery 27 (1) (2022)
Patrick Michael Jedlowski
Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS). Journal of cutaneous medicine and surgery 27 (1) (2022)
Patrick Michael Jedlowski
Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS). Journal of cutaneous medicine and surgery (2022)
Patrick Michael Jedlowski, Mahdieh Fazel Jedlowski
Topical ophthalmic beta-blockers are associated with ocular pseudopemphigoid: A pharmacovigilance study of antiglaucoma medications utilising the FDA adverse event reporting system. The Australasian journal of dermatology 63 (2) (2022)
Patrick Michael Jedlowski
Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS). Journal of cutaneous medicine and surgery 27 (1) (2022)
Patrick Michael Jedlowski, Mahdieh F Jedlowski
Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schönlein purpura: A case report and review. The Journal of dermatology (2021)
Patrick Michael Jedlowski, Mahdieh F Jedlowski, Robert J Segal
Polydactylous Squamous Cell Carcinoma of the Nail Unit: A Structured Review of the Literature. Journal of cutaneous medicine and surgery 25 (3) (2020)
Patrick Michael Jedlowski, Gina Rainwater, So Yeon Paek
Punctate porokeratosis-pruritic and hyperkeratotic papules on the palms and feet. Proceedings (Baylor University. Medical Center) 33 (3) (2020)
Mahdieh Fazel, Patrick Michael Jedlowski
Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma. Case reports in immunology 2019 (2019)
Patrick Michael Jedlowski, Charisse H Te, Robert J Segal, Maryam T Fazel
Cutaneous Adverse Effects of Diabetes Mellitus Medications and Medical Devices: A Review. American journal of clinical dermatology 20 (1) (2019)